Related Experiment Video

Updated: Aug 11, 2026

Pentylenetetrazole-Induced Kindling Mouse Model
07:06

Pentylenetetrazole-Induced Kindling Mouse Model

Published on: June 12, 2018

[Seizures in phenylketonuria]

J Czochańska, A Wilmowska, J Borzymowska

    Neurologia I Neurochirurgia Polska
    |January 1, 1977
    PubMed

    Insights

    Late-diagnosed phenylketonuria (PKU) significantly increases seizure risk, particularly severe epilepsy like salaam seizures, in children. Early intervention is crucial to mitigate these risks and improve outcomes.

    Area of Science:

    • Neurology
    • Pediatrics
    • Metabolic Disorders

    Context:

    • Phenylketonuria (PKU) is a rare genetic disorder.
    • Late diagnosis and treatment of PKU are associated with neurological complications.
    • Seizures are a significant concern in children with PKU.

    Purpose:

    • To investigate the prevalence and characteristics of seizures in children with phenylketonuria diagnosed and treated late.
    • To explore the relationship between seizure occurrence, severity of intellectual disability, and seizure types in this cohort.
    • To evaluate the prognostic significance of seizures and propose treatment strategies.

    Summary:

    • A study of 90 children with late-diagnosed phenylketonuria revealed seizures in over 50%, with salaam seizures being most common (72%).
    • Seizure frequency was significantly higher in children with severe intellectual disability.
    • Observed seizure incidence was twice that reported in literature, attributed to long-term observation and suggesting seizures are a poor prognostic indicator.

    Impact:

    • Highlights the high risk of seizures in inadequately treated PKU.
    • Suggests the need for anticonvulsant therapy in addition to dietary management for PKU patients with seizures.
    • Emphasizes the importance of early diagnosis and intervention to prevent severe neurological sequelae.

    More Related Videos

    Microdialysis of Excitatory Amino Acids During EEG Recordings in Freely Moving Rats08:47

    Microdialysis of Excitatory Amino Acids During EEG Recordings in Freely Moving Rats

    Published on: November 8, 2018

    Behavioral Characterization of Pentylenetetrazole-induced Seizures: Moving Beyond the Racine Scale07:35

    Behavioral Characterization of Pentylenetetrazole-induced Seizures: Moving Beyond the Racine Scale

    Published on: July 8, 2025

    Related Concept Videos

    Epilepsy and Seizures: Overview01:24

    Epilepsy and Seizures: Overview

    Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
    Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
    Seizures: Classification01:13

    Seizures: Classification

    Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
    Seizures are typically classified into two main categories: focal and generalized seizures.
    Focal Seizures
    Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
    Antiepileptic Drugs: Sodium Channel Blockers01:08

    Antiepileptic Drugs: Sodium Channel Blockers

    Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
    Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
    Among the most commonly prescribed antiepileptic drugs are...
    Antiepileptic Drugs: Potassium Channel Activators01:20

    Antiepileptic Drugs: Potassium Channel Activators

    Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
    Ezogabine has gained approval as an adjunctive treatment...
    Seizures l: Introduction01:20

    Seizures l: Introduction

    Understanding seizures and epilepsy relies on key definitions that help in recognizing, classifying, and managing these disorders. These definitions provide a framework for recognizing, classifying, and managing seizure disorders.DefinitionsA seizure is a sudden, abnormal burst of electrical activity in the brain that can cause changes in awareness, movement, sensation, or behavior, depending on the area involved. Epilepsy is a chronic condition characterized by recurrent, unprovoked seizures,...
    Seizures ll: Types01:19

    Seizures ll: Types

    Seizures are sudden bursts of abnormal electrical discharge in the brain that interfere with normal function. They are commonly divided into three groups: focal seizures, generalized seizures, and other types that do not fit neatly into either category.Focal SeizuresFocal seizures begin in a single brain region. When awareness is preserved, they are called focal aware seizures and may cause sensations such as tingling, unusual smells, or flashing lights. When awareness is impaired, they are...